Is there a relationship between the first-day results of anti-VEGF therapy for macular edema due to vascular diseases and longterm outcomes?

Related authors

• Betul Onal Gunay
• Gurkan Erdogan
• Irfan Akalin
• Ahmet Kalkisim
• Cenap Mahmut Esenulku
• Murat Gunay

Related articles

• Age-related macular degeneration: a review of current therapies and new treatments
• Three versus five intravitreal aflibercept injections as the initial loading phase in the treatment of diabetic macular edema: one-year results
• Changes in the ganglion cell complex thickness after anti-VEGF treatment for diabetic macular edema
• Evaluation of contrast sensitivity in non-high-risk proliferative diabetic retinopathy treated with panretinal photocoagulation with and without intravitreal injections of ranibizumab
• Prospective evaluation of the effectiveness of combined treatment of macular edema secondary to retinal vein occlusion with intravitreal bevacizumab and dexamethasone implants
• Predictive value of the characteristics of intraretinal cystoid spaces on early response to antivascular endothelial growth factor treatment in patients with cystoid diabetic macular edema
• Profile of patients treated with intravitreal antiangiogenics in a Brazilian public service with high level of complexity
• Should intravitreal dexamethasone implant in refractory diabetic macular edema be used as an adjuvant therapy or switch therapy?
• Impact of serous macular detachment on visual recovery in retinal vein occlusion treatment
• Aflibercept treatment for macular edema with and without serous retinal detachment due to branch retinal vein occlusion

Click here to search